Get started
Author

Dominique Becquart

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
2001 · Henning Mouridsen, Mikhail Gershanovich, et al. · Journal of Clinical Oncology · 1,019
PDF
Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group
2003 · Henning Mouridsen, Mikhail Gershanovich, et al. · Journal of Clinical Oncology · 748
Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced?
1999 · Peter A. van Dam, Jan DeCloedt a, et al. · American Journal of Obstetrics and Gynecology · 129
Tumor lysis syndrome in a patient with metastatic merkel cell carcinoma
1991 · L. Y. Dirix, A. Prove, et al. · Cancer · 50
PDF
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients
2003 · M.A Nooij, J.C.J.M de Haes, et al. · European Journal of Cancer · 49
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
2009 · N Tubiana-Mathieu, P Bougnoux, et al. · British Journal of Cancer · 48
Superiority of Letrozole to Tamoxifen in the First-Line Treatment of Advanced Breast Cancer: Evidence from Metastatic Subgroups and a Test of Functional Ability
2004 · H. Mouridsen, Y. Sun, et al. · The Oncologist · 47
PDF
Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma
1991 · F. Calabresi, M. Aapro, et al. · Annals of Oncology · 43
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer
1990 · J.P. Sculier, J. Klastersky, et al. · Annals of Oncology · 28
PDF
Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium)
1985 · J. Klastersky, J. P. Sculier, et al. · Cancer · 27
Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study
2007 · Patrick Neven, Robert Paridaens, et al. · Breast Cancer Research and Treatment · 18
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: A pilot study by the lung cancer working party (Belgium)
1987 · J P Sculier, J Klastersky, et al. · Lung Cancer · 15
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer
1988 · J.P. Sculier, J. Klastersky, et al. · European Journal of Cancer and Clinical Oncology · 11
Oral versus intramuscular high-dose medroxyprogesterone acetate (HD-MPA) in advanced breast cancer. A randomized study of the Belgian Society of Medical Oncology.
1986 · R Paridaens, D Becquart, et al. · PubMed · 9
2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)
2007 · N. Tubiana-Mathieu, P. Bougnoux, et al. · European Journal of Cancer Supplements · 5
Optimal tolerance of an all-oral combination chemotherapy (CT) of oral vinorelbine (NVBo), capecitabine (C) with/without trastuzumab (T) in metastatic breast cancer (MBC) patients (pts): Safety Results of two international multicenter studies
2006 · A. Chan, N. Tubiana, et al. · Journal of Clinical Oncology · 5
Phase II study of the combination of oral vinorelbine (NVBo), capecitabine (X), and trastuzumab (H) in HER2-positive, metastatic breast cancer (MBC): Recent analysis of the results with a median follow-up of 44 months.
2010 · L. B. Petruzelka, V. Ganju, et al. · Journal of Clinical Oncology · 4
Binding of serum ferritin to concanavalin A in patients with malignancy.
1986 · L Muylle, P Blockx, et al. · PubMed · 4
Prostacyclin, thromboxane and prostaglandin F2 alpha; plasma levels in breast cancer.
1986 · I Vergote, G Laekeman, et al. · PubMed · 4
Dysgerminoma of the ovary in association with XY gonadal dysgenesis
1983 · I. Vergote, V. Dieleman, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 4
PDF
All-oral combination of oral vinorelbine (NVBo) and capecitabine (X) in HER2-negative metastatic breast cancer (MBC): latest results of a multicenter, international phase II trial with a median follow-up of 37.7 months.
2009 · N Tubiana-Mathieu, P Bougnoux, et al. · Cancer Research · 3
Efficacy of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) triple combination (NVBoXH) in HER2-positive metastatic breast cancer (MBC): First results of an international phase II trial
2007 · A. Chan, V. Ganju, et al. · Journal of Clinical Oncology · 3
Phase II trial of fotemustine in advanced colorectal cancer
1990 · H. Bleiberg, D. Becquart, et al. · European Journal of Cancer and Clinical Oncology · 3
5055 High efficacy of the combination of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated results of an international phase II trial with a median follow-up of 39 months
2009 · A. Chan, V. Ganju, et al. · European Journal of Cancer Supplements · 2
Multicenter international phase II study of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) triple combination in HER2-positive metastatic breast cancer (MBC): updated results with a longer follow-up.
2009 · A Chan, V Ganju, et al. · Cancer Research · 2
Works count: 43
Citation count: 2,289
H-index: 12
I10-index: 13
Year
Topic
Type